Skip Navigation


Carcinogenesis Advance Access originally published online on October 17, 2006
Carcinogenesis 2007 28(3):672-676; doi:10.1093/carcin/bgl181
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/3/672    most recent
bgl181v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Banerjee, M.
Right arrow Articles by Giri, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banerjee, M.
Right arrow Articles by Giri, A. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Polymorphism in the ERCC2 codon 751 is associated with arsenic-induced premalignant hyperkeratosis and significant chromosome aberrations

Mayukh Banerjee1, Jyotirmoy Sarkar1, Jayanta K. Das2, Angshuman Mukherjee3, Ajoy K. Sarkar4, Lakshmikanta Mondal5 and Ashok K. Giri1,*

1 Molecular and Human Genetics Division, Indian Institute of Chemical Biology Kolkata, India
2 West Bank Hospital, Howrah India
3 Vivekananda Institute of Medical Sciences, Kolkata India
4 Peerless Hospital and B.K Roy Research Centre Kolkata, India
5 Regional Institute of Ophthalmology, Calcutta Medical College Kolkata, India

*To whom correspondence should be addressed at: Molecular and Human Genetics Division, Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Jadavpur, Kolkata 700 032, India Tel: +91 33 2473 3491/0492/6793; Fax: +91 33 2473 5197; E-mail: akgiri15{at}yahoo.com; akgiri{at}iicb.res.in

In West Bengal, India more than 6 million people are exposed to high levels of arsenic through drinking water. Since, only 15–20% of the exposed individuals show arsenic-induced skin lesions, it is assumed that genetic variation might play an important role in arsenic toxicity and carcinogenicity. Arsenic exposure often leads to the development of hyperkeratosis, the precursor of arsenic-induced skin cancer. ERCC2 (excision repair cross-complementing rodent repair deficiency, complementation group 2) is a nucleotide excision repair pathway gene, and its SNPs have been implicated in several types of epithelial cancers. We investigated the possible association of ERCC2 codon 751 A->C polymorphism (lysine to glutamine) with arsenic-induced hyperkeratosis and correlated ERCC2 genotypes with increased frequencies of chromosomal aberration to ascertain whether any genotype leads to sub-optimal DNA repair. For this association study, 318 unrelated arsenic exposed subjects (165 with hyperkeratosis and 153 without any arsenic-induced skin lesions), drinking water contaminated with arsenic to a similar extent, were recruited. Genotyping was done through PCR–RFLP procedure. Lys/Lys genotype was significantly over-represented in the arsenic-induced hyperkeratosis-exhibiting group [odds ratio (OR) = 4.77, 95% confidence interval (CI) = 2.75–8.23]. A statistically significant increase in both CA/cell and percentage of aberrant cells was observed in the individuals with AA genotype compared to those with AC or CC genotype combined (P < 0.01) in each of the two study groups, as also, in the total study population. This study indicates that ERCC2 codon 751 Lys/Lys genotype is significantly associated with arsenic-induced premalignant hyperkeratosis and is possibly due to sub-optimal DNA repair capacity of the ERCC2 codon 751 Lys/Lys genotype.

Abbreviations: CA, chromosomal aberrations; ERCC2, excision repair cross-complementing rodent repair deficiency, complementation group 2; NER, nucleotide excision repair; XPD, xeroderma pigmentosum group D

Received June 30, 2006; revised September 13, 2006; accepted September 20, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mineral MagHome page
D. Mondal, A. Hegan, L. Rodriguez-Lado, M. Banerjee, A. K. Giri, and D. A. Polya
Multiple regression analysis of As ground-water hazard and assessment of As-attributable human health risks in Chakdha Block, West Bengal
Mineralogical Magazine, February 1, 2008; 72(1): 461 - 465.
[Full Text] [PDF]


Home page
Cancer Res.Home page
M. Vujcic, M. Shroff, and K. K. Singh
Genetic Determinants of Mitochondrial Response to Arsenic in Yeast Saccharomyces cerevisiae
Cancer Res., October 15, 2007; 67(20): 9740 - 9749.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.